Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
The goal of the DAPT Study is to bring clarity to the global medical community regarding the benefits of 12 versus 30 months of dual antiplatelet therapy in preventing stent thrombosis and major adverse cardiovascular and cerebrovascular events (MACCE) in PCI patients treated with drug-eluting stents.
